Consolidated Portfolio Review Corp Has $328,000 Holdings in Intuitive Surgical, Inc. $ISRG

Consolidated Portfolio Review Corp boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 43.6% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 603 shares of the medical equipment provider’s stock after purchasing an additional 183 shares during the period. Consolidated Portfolio Review Corp’s holdings in Intuitive Surgical were worth $328,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of ISRG. Brighton Jones LLC lifted its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the period. NBC Securities Inc. acquired a new stake in Intuitive Surgical in the 1st quarter valued at $135,000. Merit Financial Group LLC increased its position in shares of Intuitive Surgical by 17.2% during the first quarter. Merit Financial Group LLC now owns 7,811 shares of the medical equipment provider’s stock worth $3,869,000 after acquiring an additional 1,147 shares in the last quarter. ST Germain D J Co. Inc. increased its holdings in Intuitive Surgical by 69.8% during the 1st quarter. ST Germain D J Co. Inc. now owns 73 shares of the medical equipment provider’s stock worth $36,000 after purchasing an additional 30 shares in the last quarter. Finally, HBW Advisory Services LLC grew its holdings in Intuitive Surgical by 11.1% during the first quarter. HBW Advisory Services LLC now owns 542 shares of the medical equipment provider’s stock worth $268,000 after buying an additional 54 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. BTIG Research reaffirmed a “buy” rating and set a $571.00 price objective on shares of Intuitive Surgical in a report on Wednesday. Piper Sandler reiterated an “overweight” rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday, September 26th. Finally, Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Fourteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $443.01 on Friday. The company has a market capitalization of $158.81 billion, a P/E ratio of 61.79, a PEG ratio of 4.59 and a beta of 1.61. The stock has a 50 day moving average price of $464.42 and a two-hundred day moving average price of $500.22. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company’s revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.78 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.